AbbVie Stock Will $300: Timing and Risks to Watch
AbbVie’s Q1 2026 results show strong immunology growth even as biosimilar challenges weigh on revenue. Analysts debat...
Need a credit card that rewards you for gas purchases? Explore our recommendations for the best cash back options available.
28,303 articlesAbbVie’s Q1 2026 results show strong immunology growth even as biosimilar challenges weigh on revenue. Analysts debat...
Alphabet's AI ambitions are under scrutiny as cloud momentum and big-capex raise the stakes. Here’s what investors sh...
As July unfolds, Meta’s AI cloud strategy becomes a potential catalyst for margins and growth. Here’s how today’s act...
If SpaceX shifts a sizable slice of its IPO to everyday investors, the market could see bigger demand and new pricing...
A new MLP income ETF employs a covered call overlay to lift yield beyond AMLP, drawing attention from income-focused ...
Meta Platforms is pursuing a bold $9 trillion valuation by 2031 even after a blistering market setback. The plan hing...
Cloudflare signals a bold pivot to AI-enabled edge infrastructure, reorganizing around AI and cutting roughly one-fif...
When a celebrity opens up about family life, it offers more than moments to admire. This article breaks down the fina...
Global markets rose late Sunday as the U.S. and Iran signaled a pause in hostilities and agreed to talks, easing fear...
The crypto world pivoted last week as a regulator-approved platform hit a $1 billion weekly volume in perpetual futur...
A 2024 business sale can push couples into IRMAA tiers in 2026. The two-year lookback means higher Medicare costs for...
A high-profile insider sale at LegalZoom has investors asking questions. This article breaks down what the move could...